Primary cutaneous post-transplant lymphoproliferative disorder that rapidly improved upon reduction of immunosuppression and addition of everolimus

J Dermatol. 2020 Nov;47(11):e406-e408. doi: 10.1111/1346-8138.15549. Epub 2020 Aug 11.

¹ Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
² Atomic Bomb Disease and Hibakusha Medicine Unit, Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
³ Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
⁴ Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

No abstract available

Publication types